Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 762, pseudogene (RN7SL762P)

Target
RN7SL762P
Molecular classification
Other, Pseudogene, Non-coding RNA
01

Overview

RN7SL762P is a pseudogene derived from the 7SL RNA gene, a crucial structural noncoding RNA involved in the signal recognition particle (SRP) ribonucleoprotein complex[3][5][4]. Pseudogenes are generally nonfunctional relics of once-functional genes that persist in the genome but do not code for a biologically active product[4]. RN7SL762P does not produce a functional RNA or protein, is not a receptor/enzyme/transporter, and is not considered a therapeutic target. The 7SL RNA parent gene functions as part of SRP to regulate protein targeting to the endoplasmic reticulum[1][6], but RN7SL762P only shares sequence similarity without functional activity. There is no evidence this pseudogene has a role in disease, is regulated as a biomarker, interacts with drugs, or presents notable safety issues for therapeutic development. RN7SL762P should *not* be considered a drug, diagnostic, or therapeutic target in molecular pharmacology or disease research. Its listing as a "target" is incorrect, as it lacks the necessary biological activities[4][5].

Other names
RN7SL762PRNA, 7SL, cytoplasmic 762, pseudogene
02

Mechanism of action

None known; not targeted by drugs

03

Biological functions

None (as a pseudogene); parent gene functions in signal recognition particle assembly[3][4][5][6]
04

Disease associations

None established; genomic pseudogenes rarely have defined disease roles[4][5]
05

Safety considerations

None relevant; not targeted pharmacologically
06

Interacting drugs

None known; not a functional molecular target
07

Biomarkers

None known

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 762, pseudogene (RN7SL762P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 762, pseudogene (RN7SL762P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call